MedTrace Logo

The Helsinki Unruptured Intracranial Aneurysm Quality of Care Study

NCT06147102 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 173

Last updated 2024-10-10

No results posted yet for this study

Summary

A research-initiated prospective cohort study with the aim to assess the effectivity, safety and long-term outcomes after surgical and endovascular treatment of unruptured intracranial aneurysms. All consecutive patients with a non-ruptured intracranial aneurysms treated at Helsinki University Hospital will be included. Safety is measured by postoperative magnetic resonance imaging (MRI) taken 1-3 days after the treatment, treatment-related complications and functional outcome at three months. Effectiveness is measured by angiographic results and assessment of long-term bleeding from the treated aneurysm. Other outcomes include risk of developing epilepsy, getting a new stroke, and dementia on long-term follow-up.

Conditions

  • Intracranial Aneurysm

Interventions

PROCEDURE

Surgery

Surgical treatment for the unruptured intracranial aneurysm

PROCEDURE

Endovascular

Endovascular treatment for the unruptured intracranial aneurysm

Sponsors & Collaborators

  • Helsinki University Central Hospital

    lead OTHER

Principal Investigators

  • Rahul Raj, MD, PhD · Helsinki University Central Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06147102 on ClinicalTrials.gov